Wesley K. Kroeze

6.7k total citations · 3 hit papers
38 papers, 4.9k citations indexed

About

Wesley K. Kroeze is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Wesley K. Kroeze has authored 38 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in Wesley K. Kroeze's work include Receptor Mechanisms and Signaling (30 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Neuropeptides and Animal Physiology (11 papers). Wesley K. Kroeze is often cited by papers focused on Receptor Mechanisms and Signaling (30 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Neuropeptides and Animal Physiology (11 papers). Wesley K. Kroeze collaborates with scholars based in United States, Denmark and Argentina. Wesley K. Kroeze's co-authors include Bryan L. Roth, Douglas J. Sheffler, Kurt Kristiansen, Xi‐Ping Huang, Katherine Lansu, John D. McCorvy, Sandra J. Hufeisen, Noah Sciaky, Herbert Y. Meltzer and Karu Jayathilake and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Wesley K. Kroeze

37 papers receiving 4.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

2004 893 citations Bryan L. Roth, Douglas J. Sheffler et al. Nature Reviews Drug Discovery profile →
H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

2003 637 citations Wesley K. Kroeze, Sandra J. Hufeisen et al. Neuropsychopharmacology profile →
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome

2015 519 citations Wesley K. Kroeze, Maria F. Sassano et al. Nature Structural & Molecular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wesley K. Kroeze United States	27	2.8k	1.9k	592	552	469	38	4.9k
Jarl E. S. Wikberg Sweden	53	3.5k 1.2×	1.7k 0.9×	860 1.5×	225 0.4×	1.2k 2.5×	231	8.3k
Vincent Setola United States	33	2.8k 1.0×	1.8k 0.9×	1.2k 2.1×	146 0.3×	290 0.6×	81	5.1k
Fang Zheng United States	34	2.0k 0.7×	1.5k 0.8×	430 0.7×	114 0.2×	532 1.1×	208	4.9k
Meritxell Canals Australia	44	4.5k 1.6×	3.5k 1.8×	343 0.6×	191 0.3×	354 0.8×	113	6.6k
Fiona H. Marshall United Kingdom	53	7.0k 2.4×	4.7k 2.4×	892 1.5×	239 0.4×	499 1.1×	100	9.3k
Douglas J. Sheffler United States	28	2.3k 0.8×	1.6k 0.8×	347 0.6×	298 0.5×	194 0.4×	63	3.6k
Georges Vauquelin Belgium	45	4.2k 1.5×	2.7k 1.4×	354 0.6×	233 0.4×	560 1.2×	224	6.5k
Enric I. Canela Spain	58	5.6k 2.0×	4.5k 2.3×	180 0.3×	282 0.5×	469 1.0×	201	9.3k
Carme Lluı́s Spain	52	4.4k 1.6×	4.2k 2.2×	141 0.2×	283 0.5×	332 0.7×	108	7.7k
Josefa Mallol Spain	54	4.3k 1.5×	3.4k 1.7×	137 0.2×	267 0.5×	365 0.8×	124	7.3k

Countries citing papers authored by Wesley K. Kroeze

Since Specialization

Citations

This map shows the geographic impact of Wesley K. Kroeze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wesley K. Kroeze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wesley K. Kroeze more than expected).

Fields of papers citing papers by Wesley K. Kroeze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wesley K. Kroeze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wesley K. Kroeze. The network helps show where Wesley K. Kroeze may publish in the future.

Co-authorship network of co-authors of Wesley K. Kroeze

This figure shows the co-authorship network connecting the top 25 collaborators of Wesley K. Kroeze. A scholar is included among the top collaborators of Wesley K. Kroeze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wesley K. Kroeze. Wesley K. Kroeze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kroeze, Wesley K., Bryan L. Roth, Xi‐Ping Huang, & Seiji Sato. (2020). Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc. UNC Libraries.

Yaksh, Tony L., Kelly A. Eddinger, Zhenping Wang, et al.. (2019). Mast Cell Degranulation and Fibroblast Activation in the Morphine-induced Spinal Mass. Anesthesiology. 131(1). 132–147. 20 indexed citations

Lansu, Katherine, Joel Karpiak, Jing Liu, et al.. (2017). In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nature Chemical Biology. 13(5). 529–536. 217 indexed citations

Sato, Seiji, Xi‐Ping Huang, Wesley K. Kroeze, & Bryan L. Roth. (2016). Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc. Molecular Pharmacology. 90(6). 726–737. 44 indexed citations

Roth, Bryan L. & Wesley K. Kroeze. (2015). Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily. Journal of Biological Chemistry. 290(32). 19471–19477. 61 indexed citations

Huang, Xi‐Ping, Joel Karpiak, Wesley K. Kroeze, et al.. (2015). Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature. 527(7579). 477–483. 197 indexed citations

Vardy, Eyal, Maria F. Sassano, Andrew J. Rennekamp, et al.. (2015). Single Amino Acid Variation Underlies Species-Specific Sensitivity to Amphibian Skin-Derived Opioid-like Peptides. Chemistry & Biology. 22(6). 764–775. 11 indexed citations

Kroeze, Wesley K., Maria F. Sassano, Xi‐Ping Huang, et al.. (2015). PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nature Structural & Molecular Biology. 22(5). 362–369. 519 indexed citations breakdown →

Ozawa, Akihiko, Iris Lindberg, Bryan L. Roth, & Wesley K. Kroeze. (2010). Deorphanization of Novel Peptides and Their Receptors. The AAPS Journal. 12(3). 378–384. 26 indexed citations

10.

Yadav, Prem N., Atheir I. Abbas, Martilias S. Farrell, et al.. (2010). The Presynaptic Component of the Serotonergic System is Required for Clozapine's Efficacy. Neuropsychopharmacology. 36(3). 638–651. 51 indexed citations

11.

Kroeze, Wesley K. & Bryan L. Roth. (2006). Screening the receptorome. Journal of Psychopharmacology. 20(4_suppl). 41–46. 2 indexed citations

12.

Elphick, Gwendolyn F., William Querbes, Gretchen V. Gee, et al.. (2004). The Human Polyomavirus, JCV, Uses Serotonin Receptors to Infect Cells. Science. 306(5700). 1380–1383. 331 indexed citations

13.

Roth, Bryan L., Douglas J. Sheffler, & Wesley K. Kroeze. (2004). Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nature Reviews Drug Discovery. 3(4). 353–359. 893 indexed citations breakdown →

14.

Kroeze, Wesley K., Sandra J. Hufeisen, S Steinberg, et al.. (2003). H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs. Neuropsychopharmacology. 28(3). 519–526. 637 indexed citations breakdown →

15.

Watkins, Kenneth C., Bryan L. Roth, Wesley K. Kroeze, et al.. (2002). Similar ultrastructural distribution of the 5-HT2A serotonin receptor and microtubule-associated protein MAP1A in cortical dendrites of adult rat. Neuroscience. 113(1). 23–35. 79 indexed citations

16.

Kristiansen, Kurt, Wesley K. Kroeze, David L. Willins, et al.. (2000). A Highly Conserved Aspartic Acid (Asp-155) Anchors the Terminal Amine Moiety of Tryptamines and Is Involved in Membrane Targeting of the 5-HT2A Serotonin Receptor But Does Not Participate in Activation via a “Salt-Bridge Disruption” Mechanism. Journal of Pharmacology and Experimental Therapeutics. 293(3). 735–746. 101 indexed citations

17.

Шапиро, Д. А., Kurt Kristiansen, Wesley K. Kroeze, & Bryan L. Roth. (2000). Differential Modes of Agonist Binding to 5-Hydroxytryptamine2A Serotonin Receptors Revealed by Mutation and Molecular Modeling of Conserved Residues in Transmembrane Region 5. Molecular Pharmacology. 58(5). 877–886. 14 indexed citations

18.

Kroeze, Wesley K., et al.. (1999). Structure and Function of the Third Intracellular Loop of the 5‐Hydroxytryptamine_2A Receptor: The Third Intracellular Loop Is α‐Helical and Binds Purified Arrestins. Journal of Neurochemistry. 72(5). 2206–2214. 88 indexed citations

19.

Willins, David L., et al.. (1998). G protein-coupled receptor (GPCR) trafficking in the central nervous system: relevance for drugs of abuse. Drug and Alcohol Dependence. 51(1-2). 73–85. 52 indexed citations

20.

Sengeløv, Henrik, Lars Kjeldsen, Wesley K. Kroeze, Madelyn Berger, & Niels Borregaard. (1994). Secretory vesicles are the intracellular reservoir of complement receptor 1 in human neutrophils.. The Journal of Immunology. 153(2). 804–810. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact